CABA vs. CRGX, CGEM, OPK, RGNX, IMTX, RLAY, HLVX, PRME, PROK, and BCRX
Should you be buying Cabaletta Bio stock or one of its competitors? The main competitors of Cabaletta Bio include CARGO Therapeutics (CRGX), Cullinan Oncology (CGEM), OPKO Health (OPK), REGENXBIO (RGNX), Immatics (IMTX), Relay Therapeutics (RLAY), HilleVax (HLVX), Prime Medicine (PRME), ProKidney (PROK), and BioCryst Pharmaceuticals (BCRX). These companies are all part of the "medical" sector.
Cabaletta Bio (NASDAQ:CABA) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, community ranking, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.
In the previous week, CARGO Therapeutics had 2 more articles in the media than Cabaletta Bio. MarketBeat recorded 4 mentions for CARGO Therapeutics and 2 mentions for Cabaletta Bio. CARGO Therapeutics' average media sentiment score of 0.33 beat Cabaletta Bio's score of 0.27 indicating that CARGO Therapeutics is being referred to more favorably in the news media.
93.2% of CARGO Therapeutics shares are held by institutional investors. 12.3% of Cabaletta Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Cabaletta Bio received 70 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 69.44% of users gave Cabaletta Bio an outperform vote.
Cabaletta Bio currently has a consensus price target of $34.33, indicating a potential upside of 164.92%. CARGO Therapeutics has a consensus price target of $29.67, indicating a potential upside of 58.22%. Given Cabaletta Bio's higher possible upside, analysts clearly believe Cabaletta Bio is more favorable than CARGO Therapeutics.
CARGO Therapeutics' return on equity of 0.00% beat Cabaletta Bio's return on equity.
Summary
CARGO Therapeutics beats Cabaletta Bio on 6 of the 11 factors compared between the two stocks.
Get Cabaletta Bio News Delivered to You Automatically
Sign up to receive the latest news and ratings for CABA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CABA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cabaletta Bio Competitors List
Related Companies and Tools
